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Abstract: The industrial development of carbohydrate-based drugs
is greatly thwarted by the typical challenges inherent in oligosac-
charide synthesis. The practical advantages of continuous-flow syn-
thesis in microreactors (high reproducibility, easy scalability, and
fast reaction optimization) may offer an effective support to make
carbohydrates more attractive targets for drug-discovery processes.
Here we report a systematic exploration of the glycosylation reac-
tion carried out under microfluidic conditions. Trichloroacetimi-
dates and thioglycosides have been investigated as glycosyl donors,
using both primary and secondary acceptors. Each microfluidic gly-
cosylation has been compared with the corresponding batch reac-
tion, in order to highlight advantages and drawbacks of
microreactors technology. As a significant example of multistep
continuous-flow synthesis, we also describe the preparation of a tri-
saccharide by means of two consecutive glycosylations performed
in interconnected microreactors.
Keywords: carbohydrates, glycosylation, flow chemistry, natural
products, oligosaccharides, glycosides
Beside peptides and nucleotides, carbohydrates are one of
the most important biopolymers found in nature, in fact
they play crucial roles as key mediators of vital molecular
recognition phenomena and signal transduction. In addi-
tion, carbohydrates are involved in other different biolog-
ical events such as bacterial and viral infections,
inflammatory processes, and tumor growth and metasta-
sis.1 All these characteristics make carbohydrates attrac-
tive targets for the design and development of new drugs.2
However, there are still severe limitations to the develop-
ment of saccharide-based drugs using traditional carbohy-
drate synthesis, even though some enormously successful
pharmaceutical compounds based on synthetic oligosac-
charides have been approved for the market during the
past decade, such as the anticoagulant fondaparinux
(ArixtraTM) and the antiviral zanamivir (RelenzaTM).
Classical carbohydrate synthesis is a multistep process
typically afflicted by laborious protecting-group manipu-
lations, often requiring tedious work-up and time-con-
suming purification steps.3 In addition the glycosylation,
the most important transformation in the chemical synthe-
sis of carbohydrates, is still a challenging task. Although
multitudinous approaches for the stereoselective forma-
tion of glycosidic bonds have been thoroughly explored
during the last two decades,4 a general method for the
preparation of different glycoconjugates has yet not
emerged, especially for large-scale production of oligo-
saccharides. As a consequence, the ideal reaction condi-
tions (in terms of the protecting-group pattern of the
condensing partners, reagents concentration, stoichiome-
try, temperature, and nature of the acidic promoter) have
to be found, in theory, for each couple of glycosylation
partners, leading to waste of time and high consumption
of precious building blocks, which are valuable synthetic
intermediates and they themselves require multistep syn-
thesis. All of these drawbacks are inherent in carbohy-
drate synthesis and represent notable obstacles for the
industrial development of carbohydrate-based pharma-
ceutical compounds. 
Continuous-flow organic synthesis carried out in microre-
actors may offer an attractive solution, since the optimiza-
tion of the reaction conditions and the subsequent scale-up
are very fast and simple.5 Due to the small dimensions and
the increased surface to volume ratio of microreactors,
mass and heat transport are significantly more efficient
than in the classic round-bottomed flask. As a result, the
reaction conditions in a continuous-flow microsystem are
homogeneous, and variables such as temperature, pres-
sure, concentration, and residence time can be easily and
very precisely controlled, improving yield, purity, and se-
lectivity. In addition, only a small amount of starting ma-
terial is required to rapidly screen multiple reaction
conditions, thus reducing the waste of precious intermedi-
ates. On the other hand, the continuous running of the mi-
croreactor or the use of multiple microreactors in parallel
allow for a simple scale-up of the optimized process. 
Because of the many practical advantages mentioned
above, the use of microfluidic reactors could speed up the
saccharide drug discovery and the development process,
in order to adequately exploit the broad potential envi-
sioned for this class of molecules in pharmaceutical and
medicinal field. Nonetheless, in comparison with other ar-
eas of chemistry the application of this technique to oligo-
saccharide synthesis is still in its infancy. In particular,
relatively few examples of glycosylations in a flow micro-
reactor system have been reported.5g,6 More recently, this
technique has been extended to the synthesis of fluorinat-
ed glycosyl amino acids7 and the photochemical coupling
of sugars via thiol-ene chemistry.8 The application of con-
tinuous-flow devices to perform the multistep synthesis of
complex molecules, that can be achieved by combining
multiple steps through a series of properly interconnected
microreactors, represents an additional advantage of this
technique.9 Such an approach would allow to circumvent
the conventional and time-consuming isolation and puri-
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fication procedures usually needed for each intermediate
product in traditional reaction sequences. The group of
Jamison exemplified this concept with the continuous-
flow multistep synthesis of nucleosides.10
With the aim of gaining more insights into the potential of
microreactors in oligosaccharide synthesis, here we report
on a study of glycosylation reaction performed under con-
tinuous-flow conditions using different glycosyl donors
and acceptors. In particular, both primary and secondary
acceptors (monosaccharides 1–3, Scheme 1) have been
used in this study, while thioglycosides and glycosyl tri-
chloroacetimidates have been selected as glycosyl donors.
Each glycosylation has been also carried out under tradi-
tional batch conditions, in order to compare the results
both in terms of chemical yield and stereoselectivity. Fi-
nally, we describe the straightforward preparation of a tri-
saccharide by means of two sequential microfluidic
glycosylations performed in two interconnected micro-
reactors.11
First, one primary (glucoside 1, Scheme 1) and two sec-
ondary acceptors (compound 2 and the more sterically
hindered glucoside 3, Scheme 1) were synthesized from
methyl α-D-glucopyranoside following known proce-
dures12 (see the Supporting Information file).
Scheme 1  Glucosyl acceptors employed in this study
Then, a panel of glycosyl donors differing for conforma-
tional rigidity and activating group at the anomeric carbon
was synthesized according to literature procedures. In par-
ticular, the most popular and widespread classes of glyco-
syl donors, trichloroacetimidates and thioglycosides, were
selected and employed in this study. Moreover, all the
glycosyl donors do not have participating groups at C-2,
so that a possible influence of the microfluidic conditions
on the glycosylation stereoselectivity could emerge.
Glucosyl trichloroacetimidates 4 and 5 (Figure 1) were
prepared as previously described.13 Ethyl- and p-tolyl
thioglycosides 6 and 7, and their corresponding more con-
formationally rigid counterparts 8 and 9 (Figure 1), were
synthesized from pentaacetylglucose14 (see the Support-
ing Information file).
Figure 1  Glucosyl donors employed in this study
All the batch glycosylations were carried out at room tem-
perature in dry dichloromethane under inert atmosphere
and quenched by addition of triethylamine after disap-
pearance of the glycosyl donor (5 min). Flow glycosyla-
tions were instead performed at room temperature
pumping into a microreactor with an internal volume of
13 μL (purchased by Micronit Microfluidics®) two dis-
tinct solutions in reagent grade dichloromethane, contain-
ing the glycosyl donor and acceptor (1.2:1 ratio, solution
A) and the acidic promoter (0.01 M TMSOTf, solution B).
In the glycosylations performed with thioglycosyl donors,
solution A contained also the N-iodosuccinimide (NIS)
required for anomeric activation. A fine tuning of the hy-
drodynamic pumping (using a conventional double sy-
ringe pump) allowed to adjust the flow rate, that is, the
residence time in the microreactor. The device is complet-
ed by a reservoir connected to the outlet of the microreac-
tor and containing a solution of triethylamine in
dichloromethane to neutralize the promoter and quench
the reaction (Figure 2). Experimental details of all batch
and microfluidic glycosylations, as well as 1H NMR spec-
tra highlighting the α/β ratios, are included in the Support-
ing Information file.
Figure 2  Representation of continuous-flow glycosylations
In the first set of experiments, the trichloroacetimidate do-
nor 4 was reacted with acceptors 1–3 (Scheme 2). Initial-
ly, the residence time of the microfluidic reactions was set
at five minutes.
Despite the use of reagent grade instead of dry solvent and
room temperature, which are unusual conditions for most
glycosylations, all the flow reactions afforded the corre-
sponding disaccharides 10–12 in moderate to good isolat-
ed yields, while the stereoselectivity was comparable with
that of the batch reactions (Table 1, entries 2, 7, and 10).
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Interestingly, when the reaction time of the microfluidic
reactions was reduced to one minute, a significant in-
crease of the chemical yields was observed (Table 1, com-
pare entries 2, 3, 7, 8, and 10, 11), while the α/β ratio
remained almost unchanged. The most sterically hindered
acceptor 3 provided exclusively the α disaccharide 12 un-
der all the conditions tested (Table 1, entries 9–11). In a
separate experiment, we investigated the influence of the
temperature on the course of the microfluidic glycosyla-
tion of acceptor 1 with donor 4 (Table 1, entries 4 and 5).
However, going from room temperature to 0 °C we ob-
served only a slight increase of the chemical yield (and a
decrease of the stereoselectivity), while at –20 °C the pre-
cipitation of the trichloroacetamide caused the micro-
channels occlusion. All the following glycosylations were
therefore performed at room temperature.
Trichloroacetimidate 5 afforded very similar results to do-
nor 4 (Scheme 2 and Table 1). The only exception was
again the glycosylation of acceptor 3. This reaction
showed high α stereoselectivity under batch conditions
(15:1 α/β ratio), and reached an excellent 19:1 with 0.5
minutes residence time in the microreactor (Table 1, en-
tries 18 and 20, respectively). On the other hand, the re-
duction of the residence time to 0.5 minutes did not bring
any apparent advantage with acceptors 1 and 2 (Table 1,
compare entries 13, 14 and 16, 17). We therefore deemed
that the good α stereoselectivity achieved only with ac-
ceptor 3 should be ascribed to matching steric effects,
rather than to a specific influence of the microfluidic con-
ditions. The residence time of one minute was then con-
sidered optimum for our system, and this value was fixed
in all the subsequent experiments.
It is reasonable to assume that the reduced diffusion dis-
tances and reaction volumes, as well as the very accurate
control of the reaction parameters ensured by the micro-
fluidic conditions allow the reactions to proceed very fast.
Undesirable side reactions, such as donor degradation,
take place with residence times longer than one minute
and may become more and more important and competi-
tive. This was also confirmed by the higher purity of the
reaction products when the glycosylations were per-
formed at one minute of residence time.
In the next stage of our investigation we studied the be-
havior of thioglycosyl donors in microreactor. It should be
emphasized that, to the best of our knowledge, the use of
thioglycoside donors in glycosylations under continuous-
flow conditions has been little explored15 in comparison
with trichloroacetimidates. 
The flow reactions were carried out by pumping in the mi-
croreactor a solution containing the donor, the acceptor
Scheme 2  Reagents and conditions: (a) TMSOTf (0.01 M), CH2Cl2.
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Table 1  Glycosylations Performed with Trichloroacetimidate Do-
nors 4 and 5
Entry Donor Acceptor Product Time 
(min)
Yield 
(%)c
α/βd
1a 4 1 10 5 66 2.4:1
2b 4 1 10 5 81 1.8:1
3b 4 1 10 1 95 1.6:1
4b 4 1 10 1 99e 1:1
5b 4 1 10 1 26f,g 1:1.8
6a 4 2 11 5 28 1:1.3
7b 4 2 11 5 50 1.3:1
8b 4 2 11 1 77 1.6:1
9a 4 3 12 5 58 1:0
10b 4 3 12 5 50 1:0
11b 4 3 12 1 85 1:0
12a 5 1 13 5 62 5:1
13b 5 1 13 1 92 3:1
14b 5 1 13 0.5 93 4:1
15a 5 2 14 5 71 6:1
16b 5 2 14 1 62 6.5:1
17b 5 2 14 0.5 65 6.5:1
18a 5 3 15 5 56 15:1
19b 5 3 15 1 60 9:1
20b 5 3 15 0.5 57 19:1
a Batch.
b Flow.
c Isolated yield.
d Determined by 1H NMR spectroscopy.
e Reaction performed at 0 °C.
f Reaction performed at –20 °C.
g Microchannels occlusion.
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and NIS, while a 0.01 M solution of TMSOTf was inject-
ed in the second inlet with a flow rate corresponding to
one minute reaction time. In this way, the activation of the
glycosyl donor by I+ takes place in the microreactor soon
after mixing the two solutions. Gratifyingly, glycosyla-
tions with thioglycosides 6–9 occurred smoothly at room
temperature under microfluidic conditions, furnishing
chemical yields and stereoselectivities mostly comparable
to batch reactions even if performed using reagent grade
dichloromethane (Scheme 3 and Table 2).
Scheme 3  Reagents and conditions: (a) NIS, TMSOTf (0.01 M),
CH2Cl2.
In particular, while flow glycosylations of acceptors 1 and
2 provided from good to high yields of the corresponding
disaccharides (Table 2, entries 2, 4, 8, 10, 14, and 18), ac-
ceptor 3 afforded significantly lower yields (10–15% less)
of disaccharides 12 and 15 than batch reactions (Table 2,
compare entries 5, 6, 11, 12, 15, 16, and 19, 20).
To ensure that the efficiency of the microfluidic glyco-
sylations is reproducible on a larger scale, we performed
a laboratory scale-up using the glycosylation of acceptor
1 with donor 4 as a model reaction. According to the gen-
eral procedure C (see the experimental section in the Sup-
porting Information file), solution A and solution B (5 mL
each) were injected into a 100 μL microreactor (purchased
by Future Chemistry®) setting the residence time to one
minute. The glycosylation occurred smoothly and provid-
ed 0.44 g of disaccharide 10 over a total time of 100 min-
utes (90% isolated yield), corresponding to a production
rate of 0.26 g/h.
These data show that both stereoselectivity and chemical
yields of the microfluidic glycosylations do not basically
differ from batch reactions. There are, however, signifi-
cant practical advantages in microfluidic glycosylations,
especially in view of an industrial implementation of the
process. Optimized continuous-flow glycosylations af-
ford satisfying chemical yields with all glycosyl donors
tested and offer the unquestionable benefit of using re-
agent-grade solvents at room temperature, with no need to
remove moisture from the reaction mixture and to use an
expensive inert atmosphere.
As mentioned above, the application of flow chemistry to
multistep synthesis has been widely reported and docu-
mented either in combination with immobilized reagents,
scavengers, and catch-and-release protocols,16 or even in
a continuous-flow process through multiple microreactors
without additional components.17,9 However, to the best of
our knowledge, there are no examples of one-flow multi-
step synthesis of oligosaccharides that would be a crucial
issue to convincingly establish the microfluidic devices as
valuable tools to speed up and expand the industrial devel-
opment of saccharide-based drugs. Taking advantage of
the distinctive mode of activation of trichloroacetimidates
and thioglycosides, we anticipated that two consecutive
glycosylations could be combined in a single procedure
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Table 2  Glycosylations Performed with Thioglycosyl Donors 6–9
Entry Donor Acceptor Product Time 
(min)
Yield 
(%)c
α/βd
1a 6 1 10 5 71 1:1
2b 6 1 10 1 81 1.4:1
3a 6 2 11 5 69 2:1
4b 6 2 11 1 67 1.8:1
5a 6 3 12 5 90 3.5:1
6b 6 3 12 1 76 5:1
7a 8 1 13 5 80 4.5:1
8b 8 1 13 1 70 3.4:1
9a 8 2 14 5 55 4.5:1
10b 8 2 14 1 56 4.4:1
11a 8 3 15 5 88 2.6:1
12b 8 3 15 1 60 3:1
13a 7 1 10 5 68 1.6:1
14b 7 1 10 1 81 1.5:1
15a 7 3 12 5 86 3.9:1
16b 7 3 12 1 69 5:1
17a 9 1 13 5 65 4:1
18b 9 1 13 1 80 4:1
19a 9 3 15 5 88 2.9:1
20b 9 3 15 1 75 4.8:1
a Batch.
b Flow.
c Isolated yield.
d Determined by 1H NMR spectroscopy.
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and carried out in two interconnected microreactors, with
no need of intermediate quenching. The experiment was
designed and accomplished as follows (Scheme 4). A di-
chloromethane solution of 2-O-acetyl-3,4,6-tri-O-benzyl-
α-D-glucopyranosyl trichloroacetimidate (16)18 and ac-
ceptor 17 – obtained from thioglycoside 9 by reductive
opening of the benzylidene acetal – and a 0.02 M di-
chloromethane solution of TMSOTf were pumped in the
first microreactor, setting the reaction time at two min-
utes. The glycosylation occurred, then the solution con-
taining the disaccharide thioglycoside 18 and TMSOTf
flowed from the outlet of the microreactor and was direct-
ly conveyed to the inlet of the second microreactor, to-
gether with a dichloromethane solution of acceptor 1 and
NIS. Eventually, the newly formed trisaccharide 19 was
recovered at the outlet of the second microreactor after
neutralization of TMSOTf with triethylamine. Chromato-
graphic purification provided trisaccharide 19 in 51%
overall yield. NMR analysis showed the exclusive forma-
tion of a β-glycosidic bond in the first glycosylation, lead-
ing to disaccharide donor 18, while the subsequent
coupling afforded a mixture of anomers (estimated as
6.3:1 α/β ratio by NMR spectroscopy) at the second gly-
cosidic linkage of trisaccharide 19. The multistep synthe-
sis of trisaccharide 19 and full characterization data of
compounds 18 and 19 are reported in the Supporting In-
formation.
We performed a systematic study to explore the applica-
tion of microreactors technology in oligosaccharide syn-
thesis. Two of the most widespread glycosyl donors,
trichloroacetimidates and thioglycosides, were coupled
with different glycosyl acceptors under batch and micro-
fluidic conditions. We found that, in comparison with tra-
ditional batch reactions, the glycosylations carried out
under continuous-flow conditions occur with very similar
stereoselectivity and comparable or even higher chemical
yield. However, microfluidic glycosylations have some
practical advantages, such as the possibility to be per-
formed in standard-grade solvent at room temperature.
Also thioglycosides, which are notoriously highly sensi-
tive to traces of moisture in the reaction mixture, afforded
the corresponding disaccharides with high efficiency.
Further benefits of microreactors derive from their use for
the multistep synthesis. Multistep flow reactions can in-
deed accelerate the development of efficient chemical
processes for the discovery and production of saccharide-
based lead compounds, enabling a drastic reduction of
manufacturing costs. As a proof of concept, we synthe-
sized a trisaccharide performing two consecutive glyco-
sylations into interconnected microreactors. The large
variety of glycosyl donors that can be activated in such a
highly specific manner enables to design the multistep
synthesis of even complex oligosaccharides profiting by
the technical ease and flexibility of microreactors.
All these characteristics feature the very promising micro-
reactors technology, but additional investigations are defi-
nitely required to explore drawbacks and potential of
microfluidic devices. The study of the solvent effect, for
example, performing the glycosylations in acetonitrile or
diethyl ether,6i,j,19 could unveil significant insights on the
application of this technique to oligosaccharide synthesis,
and further efforts in this direction are currently underway
in our laboratory.
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Scheme 4  Reagents and conditions: (a) TMSOTf (0.02 M), CH2Cl2; (b) 1 (0.05 M), NIS, CH2Cl2.
D
ow
nl
oa
de
d 
by
: I
P-
Pr
ox
y 
Un
ive
rs
ità
 d
eg
li S
tu
di
 d
i M
ila
no
, U
ni
ve
rs
ità
 d
eg
li S
tu
di
 d
i M
ila
no
. C
op
yr
ig
ht
ed
 m
at
er
ia
l.
2878 D. Cancogni, L. Lay LETTER
Synlett 2014, 25, 2873–2878 © Georg Thieme Verlag  Stuttgart · New York
Supporting Information for this article is available online
at http://www.thieme-connect.com/products/ejournals/journal/
10.1055/s-00000083.Suporting IformatinSuporting Iformatin
References and Notes
(1) (a) Varki, A. Glycobiology 1993, 3, 97. (b) Dwek, R. A. 
Chem. Rev. 1996, 96, 683.
(2) (a) Sharon, N. Biochim. Biophys. Acta 2006, 1760, 527. 
(b) Balzarini, J. Nat. Rev. Microbiol. 2007, 5, 583. (c) Ernst, 
B.; Magnani, J. L. Nat. Rev. Drug Discovery 2009, 8, 661.
(3) Sofia, M. J. Med. Chem. Res. 1998, 8, 362.
(4) (a) Toshima, K.; Tatsuta, K. Chem. Rev. 1993, 93, 1503. 
(b) Nukada, T.; Berces, A.; Zgierski, M. Z.; Whitfield, D. M. 
J. Am. Chem. Soc. 1998, 120, 13291. (c) Boltje, T. J.; 
Buskas, T.; Boons, G.-J. Nat. Chem. 2009, 1, 611. 
(d) Galonić, D. P.; Gin, D. Y. Nature (London, U.K.) 2007, 
446, 1000. (e) Lepenies, B.; Yin, J.; Seeberger, P. H. Curr. 
Opin. Chem. Biol. 2010, 14, 404. (f) Mydock, L. K.; 
Demchenko, A. V. Org. Biomol. Chem. 2010, 8, 497.
(5) (a) Pennemann, H.; Watts, P.; Haswell, S. J.; Hessel, V.; 
Löwe, H. Org. Process Res. Dev. 2004, 8, 422. (b) Watts, P. 
Curr. Opin. Drug Discovery Dev. 2004, 7, 807. (c) Dittrich, 
P. S.; Manz, A. Nat. Rev. Drug Discovery 2006, 5, 210. 
(d) Wheeler, R. C.; Benali, O.; Deal, M.; Farrant, E.; 
MacDonald, S. J. F.; Warrington, B. H. Org. Process Res. 
Dev. 2007, 11, 704. (e) Mason, B. P.; Price, K. E.; 
Steinbacher, J. L.; Bogdan, A. R.; McQuade, D. T. Chem. 
Rev. 2007, 107, 2300. (f) Sahoo, H. R.; Kralj, J. G.; Jensen, 
K. F. Angew. Chem. Int. Ed. 2007, 46, 5704. (g) Geyer, K.; 
Gustafsson, T.; Seeberger, P. H. Synlett 2009, 2382. 
(h) Noël, T.; Buchwald, S. L. Chem. Soc. Rev. 2011, 40, 
5010. (i) Anderson, N. G. Org. Process Res. Dev. 2012, 16, 
852. (j) Hartman, R. L.; McMullen, J. P.; Jensen, K. F. 
Angew. Chem. Int. Ed. 2011, 50, 7502.
(6) (a) Ratner, D. M.; Murphy, E. R.; Jhunjhunwala, M.; 
Snyder, D. A.; Jensen, K. F.; Seeberger, P. H. Chem. 
Commun. 2005, 578. (b) Geyer, K.; Codée, J. D. C.; 
Seeberger, P. H. Chem. Eur. J. 2006, 12, 8434. (c) Geyer, 
K.; Seeberger, P. H. Helv. Chim. Acta 2007, 90, 395. 
(d) Carrel, F. R.; Geyer, K.; Codée, J. D. C.; Seeberger, P. H. 
Org. Lett. 2007, 9, 2285. (e) Fukase, K.; Takashina, M.; 
Hori, Y.; Tanaka, D.; Tanaka, K.; Kusumoto, S. Synlett 
2005, 2342. (f) Tanaka, K.; Mori, Y.; Fukase, K. J. 
Carbohydr. Chem. 2009, 28, 1. (g) Tanaka, K.; Miyagawa, 
T.; Fukase, K. Synlett 2009, 1571. (h) Tanaka, K.; Fukase, 
K. Beilstein J. Org. Chem. 2009, 5, 40. (i) Tanaka, K.; Fujii, 
Y.; Tokimoto, H.; Mori, Y.; Tanaka, S. I.; Bao, G.; Siwu, E. 
R. O.; Nakayabu, A.; Fukase, K. Chem. Asian J. 2009, 4, 
574. (j) Tanaka, K.; Fukase, K. Org. Process Res. Dev. 2009, 
13, 983.
(7) Oberbillig, T.; Löwe, H.; Hoffmann-Röder, A. J. Flow 
Chem. 2012, 2, 83.
(8) Wojcik, F.; O’Brien, A. G.; Götze, S.; Seeberger, P. H.; 
Hartmann, L. Chem. Eur. J. 2013, 19, 3090.
(9) (a) Webb, D.; Jamison, T. F. Chem. Sci. 2010, 1, 675. 
(b) McQuade, D. T.; Seeberger, P. H. J. Org. Chem. 2013, 
78, 6384; and references cited therein.
(10) (a) Sniady, A.; Bedore, M. W.; Jamison, T. F. Angew. Chem. 
Int. Ed. 2011, 50, 2155. (b) Shen, B.; Jamison, T. F. Org. 
Lett. 2012, 14, 3348.
(11) This work is a major part of the PhD thesis of Damiano 
Cancogni (2014).
(12) (a) Boonyarattanakalin, S.; Liu, X.; Michieletti, M.; 
Lepenies, B.; Seeberger, P. H. J. Am. Chem. Soc. 2008, 130, 
19791. (b) Kalikanda, J.; Li, Z. Carbohydr. Res. 2011, 346, 
2380. (c) Gangadharmath, U. B.; Demchenko, A. D. Synlett 
2004, 2191.
(13) (a) Gaikwad, N. W.; Hwang, G. S.; Goldberg, I. H. Org. 
Lett. 2004, 6, 4833. (b) Izumi, M.; Fukase, K.; Kusumoto, S. 
Biosci. Biotechnol. Biochem. 2002, 66, 211. (c) Qiao, L.; 
Vederas, J. C. J. Org. Chem. 1993, 58, 3480. (d) Koch, S.; 
Schollmeyer, D.; Löwe, H.; Kunz, H. Chem. Eur. J. 2013, 
19, 7020.
(14) (a) Zhang, F.; Zhang, W.; Curran, D. P.; Liu, G. J. Org. 
Chem. 2009, 74, 2594. (b) France, R. R.; Compton, R. G.; 
Davis, B. G.; Fairbanks, A. J.; Rees, N. V.; Wadhawan, J. D. 
Org. Biomol. Chem. 2004, 2, 2195. (c) Lu, L. D.; Shie, C. R.; 
Kulkarni, S. S.; Pan, G. R.; Lu, X. A.; Hung, S. C. Org. Lett. 
2006, 8, 5995.
(15) Saito, K.; Ueoka, K.; Matsumoto, K.; Suga, S.; Nokami, T.; 
Yoshida, J. Angew. Chem. Int. Ed. 2011, 50, 5153.
(16) (a) Ley, S. V.; Baxendale, I. R.; Bream, R. N.; Jackson, P. S.; 
Leach, A. G.; Longbottom, D. A.; Nesi, M.; Scott, J. S.; 
Storer, I. R.; Taylor, S. J. J. Chem. Soc., Perkin Trans. 1 
2000, 3815. (b) Baxendale, I. R.; Deeley, J.; Griffiths-Jones, 
C. M.; Ley, S. V.; Saaby, S.; Tranmer, G. K. Chem. 
Commun. 2006, 2566. (c) Baxendale, I. R.; Ley, S. V.; 
Mansfield, A. C.; Smith, C. D. Angew. Chem. Int. Ed. 2009, 
48, 4017. (d) Baxendale, I. R.; Schou, S. C.; Sedelmeier, J.; 
Ley, S. V. Chem. Eur. J. 2010, 16, 89. (e) Martin, L. J.; 
Marzinzik, A. L.; Ley, S. V.; Baxendale, I. R. Org. Lett. 
2011, 13, 320. (f) Smith, C. J.; Smith, C. D.; Nikbin, N.; Ley, 
S. V.; Baxendale, I. R. Org. Biomol. Chem. 2011, 9, 1927. 
(g) Smith, C. J.; Nikbin, N.; Ley, S. V.; Lange, H.; 
Baxendale, I. R. Org. Biomol. Chem. 2011, 9, 1938. 
(h) Pastre, J. C.; Browne, D. L.; Ley, S. V. Chem. Soc. Rev. 
2013, 42, 8849; and references cited therein.
(17) (a) Bogdan, A. R.; Poe, S. L.; Kubis, D. C.; Broadwater, S. 
J.; McQuade, D. T. Angew. Chem. Int. Ed. 2009, 48, 8547. 
(b) Stazi, F.; Cancogni, D.; Turco, L.; Westerduin, P.; 
Bacchi, S. Tetrahedron Lett. 2010, 51, 5385. (c) Kopetzki, 
D.; Lévesque, F.; Seeberger, P. H. Chem. Eur. J. 2013, 19, 
5450.
(18) (a) Tiwari, V. K.; Kumar, A.; Schmidt, R. R. Eur. J. Org. 
Chem. 2012, 15, 2945. (b) Schmidt, R. R.; Effenberger, G. 
Carbohydr. Res. 1987, 171, 59. (c) Zhang, Z.; Zong, C.; 
Song, G.; Lv, G.; Chun, Y.; Wang, P.; Ding, N.; Li, Y. 
Carbohydr. Res. 2010, 345, 750.
(19) Tanaka, S. I.; Goi, T.; Tanaka, K.; Fukase, K. J. Carbohydr. 
Chem. 2007, 26, 369. D
ow
nl
oa
de
d 
by
: I
P-
Pr
ox
y 
Un
ive
rs
ità
 d
eg
li S
tu
di
 d
i M
ila
no
, U
ni
ve
rs
ità
 d
eg
li S
tu
di
 d
i M
ila
no
. C
op
yr
ig
ht
ed
 m
at
er
ia
l.
